Steven B. Ketchum, Chief Scientific Officer at AMARIN CORP PLC\UK (AMRN), sold 1,409,032 shares at $10.04 ($15.1M) on 2018-09-24, disclosed to the SEC on 2018-09-26.
Open-market sale of $15.1M AMRN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.04 | 529,791 | $5.3M | 35.3% |
| 2 | $10.04 | 529,791 | $5.3M | 35.3% |
| 3 | $10.94 | 49,450 | $541K | 3.6% |
| 4 | $12.00 | 100,000 | $1.2M | 8.0% |
| 5 | $13.00 | 100,000 | $1.3M | 8.6% |
| 6 | $14.00 | 100,000 |
| $1.4M |
| 9.3% |
| Total | $10.70 avg | 1,409,032 | $15.1M | 100% |
| Filing → |
| AMRN | SELL | 2021-01-29 | $6.8M | — | Filing → |
| AMRN | SELL | 2019-05-02 | $356K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $381K | — | Filing → |